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Abstract
Aims: The aim of this study was to demonstrate a prototype tool for measuring
infectivity of an aerosolized human pathogen – influenza A/PR/8/34 (H1N1) virus
– using a small-animal model in the Controlled Aerosol Test System (CATS).
Methods and Results: Intranasal inoculation of nonadapted H1N1 virus into
C57BL, BALB/c and CD-1 mice caused infection in all three species.
Respiratory exposure of CD-1 mice to the aerosolized virus at graduated doses
was accomplished in a modified rodent exposure apparatus. Weight change
was recorded for 7 days postexposure, and viral populations in lung tissue
homogenates were measured post mortem by DNA amplification (qRT-PCR),
direct fluorescence and microscopic evaluation of cytopathic effect. Plots of
weight change and of PCR cycle threshold vs delivered dose were linear to
threshold doses of ~40 TCID50 and ~12 TCID50, respectively.
Conclusions: MID50 for inspired H1N1 aerosols in CD-1 mice is between 12
and 40 TCID50; proportionality to dose of weight loss and viral populations
makes the CD-1 mouse a useful model for measuring infectivity by inhalation.
Significance and Impact of the Study: In the CATS, this mouse–virus model
provides the first quantitative method to evaluate the ability of respiratory
protective technologies to attenuate the infectivity of an inspired pathogenic
aerosol.
Introduction
Bioaerosols and transmission of respiratory diseases
Whereas aerosols and contact are accepted as modes of
transmitting many disease-causing organisms, including
Legionella pneumophila, smallpox, severe acute respiratory
syndrome (SARS), coronaviruses, rhinovirus (Fiegel et al.
2006) and tuberculosis (Wells 1934; Riley et al. 1959;
McClement and Christianson 1980), the role of bioaerosols
as a transmission mechanism for influenza is less clearly
understood (Tellier 2006; Tellier 2007a,b; Lemieux and
Brankston, 2007; Brankston et al. 2007; Tang and Li, 2007;
Lee 2007).
Although a few publications have documented the
transmissibility of influenza A through inhalation routes
(Tellier 2006, 2009), few studies to date have utilized a
mouse model to investigate susceptibility to and pathoge-
nicity of measured aerosol exposures. The lack of aerobi-
ology studies results from several factors, including the
need for specialized equipment to generate and monitor
bioaerosols, the technical difficulty involved, inconsis-
tency among reported techniques (Lore et al. 2011) and
the considerable cost of conducting this research (Sher-
wood et al. 1988). Therefore, the most commonly
described method of infecting mice with influenza virus
is through the installation of fluid into the nasal passages
(Lu et al. 1999; Govorkova et al. 2007; Gillim-Ross et al.
2008; Chen et al. 2011).
For more than 75 years, laboratory mice have served as
models for susceptibility to and pathogenesis of influenza
disease (Andrewes et al. 1934). Their low cost, small size,
relative susceptibility to the virus and ease of handling
make mice a favourable platform for studying influenza
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virus infections. The mouse is currently considered the
primary model for the evaluation of influenza antiviral
agents because it is a predictive indicator of the efficacy
of such treatments in humans (Sidwell and Smee 2004).
The use of a well-characterized mouse model is especially
important in studying the infectious pathways of new
pandemic (pdm) subtypes of influenza A. Indeed, the
latest emergence of influenza has reignited interest in the
use of mouse models (Beigel and Bray 2008).
Although mathematical models have been used for
decades (Findeisen 1935; Yeh et al. 1976; International
Commission on Radiological Protection (ICRP) 1994;
Asgharian and Anjilvel 1998; Heyder 2004) to calculate
particle deposition within the respiratory tract, such cal-
culations of particle placement are able to rationalize but
not to predict the resulting clinical effect. Animal models
allow closer approximation to a human response (Schul-
man 1968; Lowen et al. 2006; Gustin et al. 2011), and
therefore, it is important to continue to further develop
these models (Fouchier et al. 2012; Kawaoka 2012).
Experimental inhalation exposure systems are an estab-
lished tool and the subject of several reviews (Drew and
Laskin 1973; MacFarland 1983; Cheng and Moss 1995;
Jaeger et al. 2006; Wong 2007). The purpose of this study
was to identify and evaluate a mouse model as a comple-
ment to a measured-dose bioaerosol delivery apparatus
termed CATS (Controlled Aerosol Test System) for test-
ing the clinical effectiveness of media used in respiratory
protective equipment (RPE). This validation, which
includes complementary data measured postmortem, ren-
ders the mice available to serve as a detector to evaluate
the clinical significance of articles of RPE by directly
measuring the change in infectivity the protective article
causes.
Influenza animal model
Exposure to influenza virus often leads to a disease present-
ing as an acute and temporarily incapacitating infection of
the upper respiratory tract that can be fatal. Influenza
illness is often associated with occurrences of annual or
near-annual epidemics in temperate climate zones. Within
the last 100 years, influenza pandemics have occurred four
times [1918 (H1N1), 1957 (H2N2), 1968 (H3N2) and 2009
(H1N1)] (Oxford 2000). Pandemics are infrequent but
often severe events because of the emergence of novel,
unpredictable strains of influenza A virus caused by recom-
bination of genetic material from two or more circulating
virus subtypes. This antigenic shift can often lead to a new
virus subtype with the ability to jump from one species
into another, potentially naive species (e.g. avian influ-
enza), and cause a large proportion of influenza-related
deaths. A number of animal models have been studied to
evaluate new vaccines and other approaches for preventing
influenza-related disease (Gubareva et al. 1998; Ng et al.
2010). Green and Kass (1964) conducted studies on the
clearance of inhaled microbial aerosols from the murine
respiratory tract. Schulman and Kilbourne (1963) studied
mouse-to-mouse transmissibility of influenza virus.
A factor complicating viral research in animal models is
that a virus may be present in a host without causing
disease. This may be due to restrictions such as the absence
of appropriate receptors on certain cell types (e.g. tissue
tropism) and the lack of intracellular processes required to
generate infectious progeny viruses or induce cytolytic
effects. Differences in viral receptors have been documented
for respiratory epithelial cells based on location in either the
pharynx or peripheral lung (van Riel et al. 2007, 2010). In
addition, either the organism or host cell may mount an
immune response or generate intracellular molecules that
disrupt the viral effects. Therefore, differences may appear
at either the cellular or tissue level or among susceptible
hosts depending upon the method of infection, especially in
regard to aerosol exposures (Phalen et al. 2008). This study
examined these parameters related to efficient (near thresh-
old) infection versus overwhelming infection of mice by
exposure to aerosolized influenza virus.
Materials and methods
Exposure system description and operation
The CATS is an apparatus that was designed, constructed
and validated (Stone 2010; Stone et al., 2012) to deliver a
precisely measured aerosol concentration, either directly or
after passage through a filter medium, through a Nose-
Only Directed-Flow Inhalation Exposure System (NOIES;
CH Technologies, Westwood, NJ, USA, Jaeger et al. 2006)
to individual mice (Figs 1 and 2). This low-flow, single-
pass design consists of an aerosol generator, diffusion drier,
charge neutralizer, filter holder, sampling points and
NOIES unit (Stone 2010; Stone et al., 2012). The CATS
generates a biological aerosol over a range of constant
concentrations and – after conditioning and treatment, if
any is applied – delivers the particles to the nose of a
mouse constrained in a polycarbonate tube (CHT-247; CH
Technologies) as a pure respiratory exposure.
The main system components were connected using
05-inch (127-mm) stainless steel tubing with a mini-
mum number of gradual bends. In operation, a single-jet
Collison nebulizer (BGI Inc., Waltham, MA, USA),
regulated to 25–30 psi was used to atomize the viral sus-
pensions. The aerosol, which acquires surface charges
during atomization, passes through a 95-inch (23-cm)
diffusion drier and then through a 2-mCi 85Kr charge
neutralizer (TSI Inc., Shoreview, MN, USA) to restore the
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‘normal’ Boltzmann equilibrium charge distribution.
After passage through the filter holder and any filter
medium mounted in it, the aerosol enters the 12-port
NOIES, from which it exits the test system through the
HEPA-filtered exhaust. Total flow rate through the sys-
tem was regulated at the nebulizer to deliver
20 ± 01 l min1 measured on exit by a mass flow metre
(TSI Model 4043E). The entire system was designed to fit
inside a biological safety cabinet (Baker Company, San-
ford, ME, USA; SG603-ATS) for additional protection
from generated aerosols. The unique feature of the system
is an optional filter holder (Triosyn Corp, Williston, VT,
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Figure 1 Schematic of the Controlled Aerosol Test System (CATS). Live virus aerosols were used to determine MID50 of Influenza A/PR/8/34
(H1N1) in a live animal model. Each mouse’s nose (arrow) penetrates from a radially oriented constraint through the perimeter of the nose-only
inhalation exposure system (NOIES).
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Figure 2 Photograph of Controlled Aerosol Test System (CATS), with key components labelled. Not pictured: control panel, constraints and imp-
inger hook-up.
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USA), which is capable of holding filter media samples
47 mm in diameter. Smaller discs of filter media can be
accommodated with the use of reducers.
Correlation of sampling ports
Stone et al. (2012, Stone 2010) demonstrated uniform
distribution of aerosol to several ports of the CATS.
Following transport and installation of the CATS in an
animal biosafety level 3 (ABL3) facility at the University
of Nebraska Medical Center, the exposure system was
retested to verify consistency of particle counts among all
12 ports, using tap water to generate test aerosol parti-
cles. From each of the 12 exposure ports, samples of par-
ticles delivered by a single-jet Collison nebulizer were
measured in triplicate using a Scanning Mobility Particle
Sizer (SMPS) system (TSI Inc., Minneapolis, MN, USA).
The aerosol particle size and concentration were deter-
mined using 60 l min1 sheath air and 06 l min1
sample air. Data outputs from the SMPS were collected
by the Aerosol Instrument Manager® Software (ver.
8.1.0.0; TSI Inc., Minneapolis, MN, USA).
Propagation of virus
Influenza A/PR/8/34 (H1N1) virus was obtained from
American Type Culture Collection (Rockville, MD, USA) as
frozen stock (ATCC VR-1469). Virus was propagated using
CDC Unit 15G.1 protocol (Szretter et al. 2006). Titres were
performed and calculated using the Spearman–Ka¨rber
method (Armitage and Allen 1950; Finney 1964).
Particle size distribution (PSD) of influenza aerosols
To assess the PSD of aerosols containing influenza
virus, samples were taken in triplicate from the sam-
pling port located downstream from the CATS, diluted
with filtered air and routed to the SMPS. Results indi-
cated a single-mode, polydisperse aerosol in the size
range 10–400 nm.
Animal husbandry/groupings
Three strains of female mice (C57BL, BALB/c and CD-1)
were purchased from Charles River Laboratories (Portage
Facility, MI, USA). The mice were 6–8 weeks old and
ranged in weight from 18 to 30 g. Mice were randomly
divided into groups assigned to specific exposure time
points, and no more than five (all in a given exposure
group) were housed per cage. Animals were provided
rodent chow (Harlan Teklad, USA) and water ad libitum
and maintained on a 12-h light/dark cycle. All animal
work was carried out in an ABL3 facility following
institutional and regulatory procedures. To minimize ar-
tefacts caused by stress during respiratory exposure ses-
sions, mice were preconditioned daily during the week
preceding their exposure sessions (NRC 2003, 2011) by
insertion into a mouse restraint device (CH247; CH
Technologies) for a period that did not exceed the maxi-
mum exposure time for that experiment.
Infection exposure protocols
Intranasal inoculation
To select a suitable mouse strain for infection with the
influenza A/PR/8/34 (H1N1) (not mouse-adapted) strain
used in this study, two inbred (BALB/c and C57BL) and
one semi-outbred strain (CD-1) of 20–25 g female mice
were tested for susceptibility to infection by the virus.
Individual base weights were determined prior to expo-
sure, and all mice were weighed daily at a uniform,
scheduled time throughout the study. The average
weights from surviving exposed mice at day 7 were com-
pared to the averages of control mice. All mice were
euthanized by day 7 postinoculation.
The inoculum, consisting of 30 ll of virus at a concen-
tration of 474 9 107 median tissue culture infectious
dose (TCID50) ml
1, was placed intranasally into each
mouse. The dose was divided equally and placed droplet-
by-droplet by pipette into each naris of the anesthetized
(ketamine/xylazine) mouse. Following the same proce-
dure, a 1 : 10 dilution of virus stock in 19 phosphate-
buffered saline (PBS) medium was used to inoculate a
second set of mice of the same three strains. In all, five
mice per strain per dilution were used to determine
susceptibility to the virus. Three mice per strain were
used as controls. Each control mouse was intranasally
inoculated with 30 ll total 1 9 PBS medium as previously
described (Jerrells et al. 2007).
Aerosol exposure
In a preliminary study conducted to establish a baseline
dose of virus capable of causing infection following
aerosolization, the working stock of influenza virus was
diluted 1 : 30 in endotoxin-free water (Sigma, St. Louis,
MO, USA) and delivered into the Collison nebulizer at
158 9 106 TCID50 ml1. Four sets of three CD-1 mice
were emplaced in polycarbonate restraints, installed into
the NOIES with the filter holder empty, and exposed to
aerosolized virus at exposure times of 2, 6, 20 and
60 min. Aliquots of the influenza working stock
(474 9 107 TCID50 ml1 titre) were subsequently
diluted to 1 : 300 and 1 : 1000 (v/v) in endotoxin-free
water to prepare concentrations aerosolized during three
successive mouse exposure series described below. The
single-jet Collison nebulizer was charged and allowed to
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run for 5 min to stabilize the system. The bypass valve
directly upstream of the CATS directed the aerosol
through two HEPA filters connected in series until expo-
sure was initiated. Nonanesthetized mice were carefully
immobilized in the polycarbonate tubes so that the tip of
the nose projected out of an opening in the front of the
holder. The tubes were then inserted securely into a port
on the CATS. Once the animals were emplaced, the test
aerosol was directed through the system. Vents inside the
cavity of the CATS directed an airstream containing the
filtered aerosol at the nares of the mouse as her only
source of breathing air. Excess aerosol flow and exhaled
air were continuously swept away to preclude inhalation
of previously exhaled air.
A spread of delivered doses (proportional to concen-
tration, C, 9 time, t) around each dilution was achieved
by varying the time of exposure. The bioaerosol dose
received is calculated as follows:
Dpðpresented DoseÞ ¼ viral titre dilution factor
 VSF ra  Va  t
Where VSF is the ratio of viable airborne counts, in
TCID50 ml
1, to viable counts, in TCID50 ml
1, in the
Collison reservoir, and ra is the respiration rate per minute,
and Va is the tidal volume in mlA (ml of air), respectively,
of the CD-1 mouse. ra and Va are reported (Fairchild 1972)
to be 261 respirations/min and 016 mlA, respectively.
Thus, a mouse exposed for 2 min to a 300 : 1 dilution of a
suspension containing 474 9 107 TCID50 ml1 of virus
inhales a dose of
Dp ¼ 474 107 TCID50 ml1  1=300
 9 107 ml ml1A  261 resp min1
 016mlA resp1  2min
¼ 12 TCID50
Mice were exposed in groups for each preselected time
(Tables 2–4). At the end of the exposure period, the
polycarbonate tubes holding the mice were removed, and
the next group was inserted, until all mice for that series
of experiments were exposed. When time points allowed,
the mice were inserted in overlapping groups. Unused
ports were sealed with the supplier’s standard plugs. All
exposures were carried out within a biological safety cabi-
net. Control mice for 1 : 30 (158 9 106 TCID50 ml1)
and 1 : 300 (158 9 105 TCID50 ml1) exposure groups
were placed in polycarbonate tubes during the testing
equal to the maximum exposure time and exposed to
aerosols generated from endotoxin-free water (Sigma)
containing no virus. For the 1 : 1000 (474 9 104
TCID50) exposure group, two sets of controls were used.
One mouse group was exposed as earlier, while a second
group was exposed to uninfected allantoic fluid processed
in the same manner as from influenza-infected eggs.
Mice were observed and weighed each of 7 days post-
exposure. Severely distressed mice were euthanized after
the day’s weighing and, following the final weighing, all
surviving mice were euthanized by administration of an
overdose of ketamine/xylazine by intraperitoneal injec-
tion. A necropsy was conducted and selected portions of
the lungs were selected for molecular, histological or virus
culture assessment. Lung tissues aseptically placed into
27 mL of cold BD Universal Virus Transport Medium
(Becton, Dickinson and Co., Franklin Lakes, NJ, USA)
were homogenized by hand using a closed ultra tissue
grinder system (Fisher Scientific, Pittsburgh, PA, USA)
and then stored at 80°C.
Cell culture and molecular assays
TCID50/CPE and DFA assays
Starting viral titres were quantified by cell culture end-
point–dilution assays performed using Madin–Darby
canine kidney (MDCK) cells and calculated using the
Spearman–Ka¨rber method in units of log10 TCID50 ml
1.
Cell culture plates containing MDCK cells were grown
and maintained using standard cell culture techniques.
Presence of viable virus in homogenates of murine lung
tissue was qualitatively assessed by two-concentration cell
culture endpoint assays performed using MDCK cells. Cell
culture plates containing MDCK cells were grown and
maintained using standard cell culture techniques. Aliquots
(10 ml) of lung homogenates were plated in serial 1 : 10
dilutions (in serum-free Eagle’s minimal essential medium
(EMEM)) from 101 to 104 in quadruplicate on conflu-
ent cell monolayers. The samples remained in contact with
the monolayer for a 1-h incubation before 1% BSA-serum-
free EMEM with trypsin was added (bovine serum albu-
min). The plates were incubated for 5–6 days under 5%
CO2 at 37°C prior to visualization under the microscope
for cytopathic effect (CPE) or fluorescent-labelled antibody
evaluation. Test plates were read using a +/ system, in
which + showed disruption of the monolayer and 
showed that the monolayer remained confluent.
Direct fluorescent antibody assay (DFA) was used to
qualitatively determine influenza infection of the MDCK
cell line using the D3 Ultra DFA Respiratory Virus
Screening and ID Kit (Diagnostic Hybrids Inc., Athens,
OH, USA) per manufacturer’s instructions.
RNA extraction and qRT-PCR
Ribonucleic acid (RNA) was extracted from samples using
the QIAamp®MinElute®Virus Spin Kit following the man-
ufacturer’s protocol (Qiagen, Valencia, CA, USA). RNA
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amplification was performed using Invitrogen’s Super-
script III Platinum One-Step quantitative real-time poly-
merase chain reaction (qRT-PCR) kit (Invitrogen, Grand
Island, NY, USA). The qRT-PCR assay was run on the
Roche LightCycler® 480 real-time PCR System (Roche
Diagnostics, Indianapolis, IN). Assay conditions and reac-
tion volumes were used from protocols previously
described by the CDC (WHO 2009). The cycle threshold
(Ct) values from replicate runs were averaged for each
time point and rounded to two decimal places. The recom-
mended cut-off Ct value of 30 was used as the criterion for
infection.
Histological assay
Following fixation and routine processing, tissue sections
were stained with hematoxylin and eosin and reviewed
under standard light microscopy. Compared to normal
tissue, influenza-infected lungs showed lobular pneumo-
nia with interbronchial inflammation. Infected lungs also
showed focal chronic inflammatory cell infiltration with a
few neutrophils and some interstitial thickening. Figure 3
shows the infiltrates in the infected tissue compared to
uninfected tissue.
Results
Uniformity of bioaerosol distribution to test system ports
After installation in the ABL3 cabinet, a reverification
of CATS performance was conducted with water. The par-
ticle counts at each port were averaged and again seen to
be uniform within 10% (data not shown). A subsequent
delivery of 100 mg l1 sodium chloride in water showed
number mean diameter (d50,n) = 74 nm and mass mean
diameter (d50,m) = 208 nm over the range of particle
diameters from 10 to 407 nm. Figure 4 plots the coeffi-
cient of variation (COV) as a function of particle size at
the 12 ports for the NaCl aerosol measurements.
Intranasal exposure
Groups of five mice were inoculated intranasally with one
of two doses of virus and weighed daily for a week. Per
cent changes in average weights of exposed and control
groups are indicated in Table 1. The nonmouse-adapted
influenza virus produced obvious infection in all three
strains of mice used. As no difference in gross infectivity
was indicated by weight loss (Table 1), the less-expensive
CD-1 mice were selected for further study.
Aerosol exposure (158 9 106 TCID50 ml1)
Two mice were used as unexposed controls. All of the
mice survived to day 7, when they were euthanized and
necropsied, and their lung tissue was examined by three
different assays.
At all four exposure time points, mouse lung tissues
gave positive results from the qRT-PCR assay, for which
a positive value was defined to be  31 Ct. DFA and
CPE assays on the lung tissue were also all positive
(a) (b)
(c) (d)
Figure 3 (a, b) Mouse lung image after exposure to aerosolized virus; H&E staining technique. (c, d) Mouse lung image after exposure to sterile
aerosols (no virus noted).
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(Table 2). There was a direct correlation between dose
received (for convenience reckoned as Ct values (product
of concentration and exposure time)), with lower PCR
Ct values resulting from prolonged exposure. The mean
Ct value for control mice was 37, which was defined to
be a negative response. Values of 37 > Ct > 31 were
considered indeterminate. Weight losses again showed
proportionality to dose delivered. The results demon-
strated that the influenza virus remained viable and capa-
ble of causing infection in CD-1 mice when aerosolized
under test conditions.
Aerosol exposure (158 9 105 TCID50 ml1)
Because exposure to the 1 : 30 dilution of aerosolized
virus resulted in massive but graduated infection of all
tested mice, a greater dilution of the working stock was
delivered in an effort to identify a threshold infective dose.
The dilution was increased tenfold (to 1 : 300, resulting in
delivery of a 158 9 105 TCID50 ml1 dispersion from the
nebulizer and an overlap (as Ct products) of the two smal-
ler doses from the 1 : 30 dilutions), and the initial aerosol
exposure sequence was repeated. Three mice per time
point were assayed by qRT-PCR. Variation in Ct values
was observed in the 2-min exposure group, one mouse
being clearly positive as reflected by Ct values, and the
other two mice falling within the indeterminate range
(Table 3). All mice in the 6-, 20- and 60-min time points
were positive (<31 Ct) with minimal variation in Ct val-
ues. All control mice were negative (Ct values  37).
TCID50 assays were performed on mice from Group 1
at each time point. One mouse lung homogenate in
Group 1 that was indeterminate by qRT-PCR (36 Ct)
was negative by TCID50 assay. All other lung homogen-
ates tested positive by both methods.
Aerosol exposure (47 9 104 TCID50 ml1)
Although weight loss by the mice appeared to have reached
baseline at the dose delivered in 6 min at 1 : 300 dilution,
Ct results from the aerosol challenge at 1 : 300 dilution
show that all the mice exposed for 6 min or more received
an infectious dose – that is, weight loss is an indicator of
dose but Ct measurements provide better sensitivity to
detect an endpoint. In an effort to better define the thresh-
old at which viral infection occurs, the stock suspension
was further diluted to 47 9 104 TCID50 ml1 (1 : 1000),
the exposure times were reduced, the number of mice per
time group was increased to five, and two additional time
points were added to increase the range and dose of aerosol
exposure. Results of this test are shown in Table 4.
Table 1 Per cent weight loss versus controls following 30-ll intrana-
sal inoculation of influenza virus and 7-day incubation period
Mouse strain
% Weight loss after intranasal inoculation (avg)
474 9 107
TCID50 ml
1
474 9 106
TCID50 ml
1 Controls
CD57BL 282 (SD* = 07) 280 (SD = 08) 01 (SD = 06)
BALB/c 262 (SD = 07) 190 (SD = 04) 06 (SD = 03)
CD-1 258 (SD = 06) 235 (SD = 15) 02 (SD = 09)
SD, standard deviation.
*One mouse died before day 7.
Table 3 PCR Ct values from the homogenates of CD-1 murine lung
tissue exposed to bioaerosol generated from a 158 9 105
TCID50 ml
1 dilution of influenza virus over four different exposure
times are indicated in parentheses: Pos = positive, Ct < 31;
Ind = indeterminate, 37 > Ct  31; and Neg = negative, Ct  37
Exposure
time (min)
Presented
dose (TCID50) Group 1 Group 2 Group 3
2 12 Ind (36) Pos (19) Ind (36)
6 36 Pos (20) Pos (21) Pos (14)
20 120 Pos (18) Pos (19) Pos (20)
60 360 Pos (17) Pos (15) Pos (18)
Control 0 Neg Neg Neg
Table 2 Results of three assays [PCR, direct fluorescent antibody
assay (DFA) and CPE] from the homogenates of CD-1 murine lung tis-
sue exposed to an aerosol generated from 158 9 106 TCID50 ml1
(1 : 30 dilution) of influenza virus over four different exposure times
are indicated in parentheses: Pos = positive, Ct < 31; Neg = negative,
Ct  37
Exposure
time (min)
Presented
dose (TCID50)
Weight gain
(% ±SD)* PCR Ct DFA CPE
2 120 20 ± 02 Pos (23) Pos Pos
6 360 84 ± 02† Pos (18) Pos Pos
20 1200 173 ± 09 Pos (16) Pos Pos
60 3600 147 ± 18 Pos (17) Pos Pos
Control 0 +69 ± 02 Neg (37) Neg Neg
*Average weight change percentage is of all three mice on day 7
postexposure.
†1/3 mice died of unrelated cause.
8
6
4
2
0
10 110 210 310 410
Diameter (nm)
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)
Figure 4 Size dependence in coefficient of variation of sodium chlo-
ride particle counts among ports of the CATS.
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At the 3-min exposure time, no mice were positive for
influenza virus as determined by Ct value. In all four of
the longer-exposure groups, a single mouse displayed a
positive Ct value. A trend may be suggested by the pat-
tern of indeterminate values, but the quantitative Ct val-
ues show an equally unconvincing opposite trend. All of
the lung homogenates were tested by virus cell culture
assay for TCID50 and DFA. For homogenates whose Ct
value is <31, both TCID50 and DFA were positive.
Discussion
Transmission of influenza
It is accepted that influenza may be contracted through a
variety of methods including large droplet and contact
transmission. The only route of infection examined dur-
ing this study was inhalation of droplet nuclei through
nasal passageways. Results should be expected to be dif-
ferent if other mucosal surfaces had been dosed with the
same viral aerosols. This study sought only to determine
the existence and scale of a measurable threshold aerosol
infective dose in this animal model and to set parameters
– such as the mouse restraints in the experiment – that
limit other exposure.
Although this study demonstrated infectivity of the
aerosol, its residence time as dispersed fine particles was
short – hundreds of milliseconds from nozzle to nose –
and viruses are known to spontaneously lose viability, so
the importance of such bioaerosols as an environmental
component remains uncertain. However, the experiment
accurately simulates direct exposure to droplet nuclei
generated by a cough, which can accordingly be con-
cluded to be a mechanism for immediate transmission of
this virus.
Animal models
The range of states resulting from influenza virus spans
from asymptomatic infection to mild symptoms to pneu-
monia, which is often fatal. Factors such as the strain of
influenza virus that caused the illness, immune status of
the host and/or age of the affected individual play an
important role in recovery or progression of disease. This
was evident in the 2009 outbreak of influenza with the
Influenza A virus H1N1 pandemic (pdm) strain, during
which a disproportionately high percentage of morbidity
occurred in children and young adults as well as in indi-
viduals with underlying conditions such as obesity and or
diabetes (Jhung et al. 2011). Influenza A (H1N1) virus
selected for this study was chosen based on reports of its
infectivity in mice (Smee et al. 2008) – although it had
not been mouse adapted – and its known hardiness in
culture systems as a starting point for development of a
mouse model for aerosolized influenza.
Infectivity/clinical symptoms
Our results showed a significant variability in morbidity
and mortality among the mice exposed to aerosolized
influenza virus. This appears to have been owing to indi-
vidual susceptibility of the mice, because variability in the
uniformity of the aerosol delivered was found not to be sig-
nificant when each of the ports was analysed. In addition,
significant differences were noted when mice were exposed
over times ranging from 6 to 18 min with minimal or no
morbidity when a low quantity of virus was sprayed over
an extended period of time. Our preferred explanation is
that some of the mice were able to process and clear virus,
while in others, it caused clinical infection and disease.
Additionally, the hardiness of immune response to influ-
enza varies among the mice, resulting in different levels of
susceptibility. For example, in Table 3 at the lowest expo-
sure time, one of the three mice was positive for infection,
whereas in the lowest dose experiment (Table 4), one
mouse was positive following only 6 min of exposure.
As with many viruses, influenza produces a significant
number of defective particles incapable of causing infec-
tion (Huang 1973; Pathak and Nagy 2009). This is
further demonstrated by the wide variation – ranging
from hundreds to thousands – in reported gene copy
(total virions)-to-TCID50 (infectious virion fraction) ratio
(Yang et al. 2011). Sidorenko and Reichl (2004) devel-
oped a mathematical model describing the complete life
cycle of influenza A in animal cells. This model, based on
the multiplicity of infection (MOI) of 10 virions per cell,
suggests that influenza replicates within 5 h postinfection
and produces up to 8000 progeny virions before cell
death occurs. Perrott et al. (2009) reported a detection
Table 4 PCR Ct values from homogenates of CD-1 murine lung tis-
sue exposed to aerosol generated from a 474 9 104 TCID50 ml1
dilution of influenza virus over five different exposure times are indi-
cated in parentheses: X = mouse death; Pos = positive, Ct < 31;
Ind = indeterminate, 37 > Ct  31; and Neg = negative, Ct  37
Exposure
time
(min)
Presented
dose
(TCID50)
Group
1
Group
2
Group
3
Group
4
Group
5
3 6 Neg Neg Neg Neg Neg
6 12 Neg Neg Neg Neg Pos
(22)
9 18 Ind
(33)
X Neg Ind
(37)
Pos
(20)
12 24 Ind
(31)
Neg Neg Pos
(23)
Neg
18 36 Ind
(33)
Ind
(33)
Pos
(27)
Ind
(37)
Neg
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level for influenza A (H1N1) to be 1 TCID50 for using
qRT-PCR and 01 TCID50 using nested qRT-PCR. Recog-
nizing that a direct correlation may not always exist
between a method that detects viable organisms and one
based on viral genomes, our system showed excellent cor-
relation between classical virology methods, morphology
based on histological examination, clinical features and
molecular quantification by qRT-PCR.
Influenza infection in mice has been monitored by sev-
eral different parameters including mean time to death,
lung weight and change in body weight (Sidwell and
Smee 2000). However, these indicators are difficult to
interpret when the infectivity and challenge dose of the
virus does not clinically manifest an illness (morbidity or
mortality). Therefore, we utilized qRT-PCR in compari-
son with TCID50 to minimize the variability. Virus
replication in lung tissue is considered the most informa-
tive endpoint for efficacy studies because even modest
changes in virus load can have a large impact on
survivability (Haga and Horimoto 2010).
Assays of postsacrifice tissue samples from the mice were
uniformly positive in the 1 : 30 dilution series. In contrast
with the data shown in Fig. 4, in the 1 : 300 dilution series
only, the 2-min exposure (12 TCID50 dose) group con-
tained subjects that were not unequivocally positive for
infection, both by Ct (2 of 3) and by CPE (1 of 3). One-way
ANOVA and a two-tailed t-test did not find any statistical dif-
ferences between the change in the mouse’s weight and the
PCR data; however, a more precise threshold value and sta-
tistical significance of this difference can be expected when
the number of mice (n) in each exposure group is increased.
Likewise, the two sets of subjects that shared Ct products
(2 min 9 1 : 30 and 20 min 9 1 : 300, and 6 min 9
1 : 30 and 60 min 9 1 : 300) appear to show increased
sensitivity with increasing aerosol concentration, which
could be taken to imply that an acute exposure leads to
greater infectivity than the same dose experienced more
gradually. Although this interpretation is intuitively reason-
able, the volume of data supporting it is too limited to
justify such a conclusion.
Estimate of infective dose
Owing to logistical constraints in the ABL-3 facility, the
PSD was not measured during the exposures. However,
Stone et al. (2012; Stone 2010) measured bioaerosol par-
ticles in the range 100~500 nm for a slightly smaller virus
(MS2 coli phage) in the same apparatus. The absorbed
dose was likely slightly smaller than the presented dose
because deposition of inspired particles in this size range
is incomplete and size dependent (Stuart 1973; Clay and
Clarke 1987; Heyder 2004). A plot of weight loss vs calcu-
lated inhaled dose (Fig. 5) was fitted to a straight line,
which intersects the mean weight change of the control
group at approximately 40 TCID50. A third series of expo-
sures was performed to a 1 : 1000 dilution, intended to
improve definition of the threshold dose for weight loss;
however, the results were equivocal, likely because the
delivery was gradual enough that the mice developed an
immune response that was able to manage the challenge,
and/or the n of five was too small to average out what we
presume to have been idiosyncrasies among the subjects.
Our results showed that qRT-PCR was more sensitive
or that an excess of genome was present in comparison
with the number of infectious virions as determined by
TCID50 and DFA assays. As the gold standard (Schrau-
wen et al. 2011) for determining the MOI has been
TCID50 and quantification of virus in mice exposed to
influenza aerosols by qRT-PCR has not been previously
reported, additional confirmatory studies were needed.
We chose seven days as the terminal point for our study
based on symptomatology in humans where virus pro-
duction peaks approximately 48 h postinfection, and few
virus particles are shed after day 6 (Taubenberger and
Morens 2008). Our results showed the delivered aerosol
MID50 to be at least 12 TCID50 as determined by qRT-
PCR Ct value and significantly <40 TCID50 as determined
by obvious clinical response. However, the sample size
must be expanded in the future to achieve greater resolu-
tion and statistical significance. In addition, future studies
will utilize the influenza virus A (H1N1) pdm strain to
determine variation in MID50 between the two strains.
Future work
The data and methods presented here contribute to a
fundamental basis for refining studies of aerosol delivery
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Figure 5 Average weight change for mouse exposure groups over
three different received aerosol doses: = 1 : 30 dilution series;
= 1 : 300 dilution series; = 1 : 1000 dilution series. Plot shows
overlap between doses received and change in weight,
MID50  intercept of line with control value.
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of particles into animal models for study of a variety of
clinical subjects, such as infectious doses and vaccine
delivery. Further work will be needed to more precisely
define the median infective dose (MID50) of the current
influenza strain in the CD-1 mouse, and to better under-
stand the effect of bioaerosol ageing and dose rate on
infectivity.
Work presented herein validates aerosolization of one
organism and delivery by a pure respiratory pathway into
one murine host as a technique for assaying infectivity in
the challenging bioaerosol. This work can serve as a
starting point for a continuation of work using other
microbial organisms and other animal hosts.
The intended application of the aerosol influenza animal
model described here is the assessment of the clinical effect
of respiratory protection devices incorporating antimicro-
bial treatments. Various approaches have been proposed to
increase the effectiveness of respiratory filtering media
including the addition of bioactive media. Although mate-
rials such as silver nanoparticles (Lala et al. 2007), copper
oxide (Borkow et al. 2010), iodinated compounds (Heim-
buch and Wander 2006) and others (Cecchini et al. 2004)
have shown biocidal potential, only the iodine vector has
been proposed (Lee et al. 2009) to operate by a noncontact
mechanism. Additional studies will focus on evaluating
such new technologies and, after replacement of the filter
holder with a larger enclosure able to collect aerosols
behind a filtering facepiece respirator (FFR) worn by an
articulated headform, on quantifying the effect on protec-
tivity of seal leakage and on optimizing the particle
removal efficiency of FFRs and other RPE to maximize net
protectivity.
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